4.7 Review

Addiction as a stress surfeit disorder

期刊

NEUROPHARMACOLOGY
卷 76, 期 -, 页码 370-382

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2013.05.024

关键词

Opponent process; Extended amygdala; Corticotropin-releasing factor; Dynorphin; Reward; Compulsive; Impulsive; Sensitization; Abstinence or withdrawal; Prefrontal cortex

资金

  1. National Institutes of Health [AA006420, AA020608, AA008459]
  2. National Institute on Alcohol Abuse and alcoholism [DA010072, DA004043, DA023597, DA004398]
  3. National Institute of Diabets and Digesttive and Kidney Diseases [DK26741]
  4. Pearson Center for Alcoholism and addiction Research
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020608, R01AA008459, P50AA006420, R37AA008459, P60AA006420] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004398, R01DA010072, R01DA023597, R01DA004043] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Drug addiction has been conceptualized as a chronically relapsing disorder of compulsive drug seeking and taking that progresses through three stages: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. Drug addiction impacts multiple motivational mechanisms and can be conceptualized as a disorder that progresses from positive reinforcement (binge/intoxication stage) to negative reinforcement (withdrawal/negative affect stage). The construct of negative reinforcement is defined as drug taking that alleviates a negative emotional state. Our hypothesis is that the negative emotional state that drives such negative reinforcement is derived from dysregulation of key neurochemical elements involved in the brain stress systems within the frontal cortex, ventral striatum, and extended amygdala. Specific neurochemical elements in these structures include not only recruitment of the classic stress axis mediated by corticotropin-releasing factor (CRF) in the extended amygdala as previously hypothesized but also recruitment of dynorphin-kappa opioid aversive systems in the ventral striatum and extended amygdala. Additionally, we hypothesized that these brain stress systems may be engaged in the frontal cortex early in the addiction process. Excessive drug taking engages activation of CRF not only in the extended amygdala, accompanied by anxiety-like states, but also in the medial prefrontal cortex, accompanied by deficits in executive function that may facilitate the transition to compulsive-like responding. Excessive activation of the nucleus accumbens via the release of mesocorticolimbic dopamine or activation of opioid receptors has long been hypothesized to subsequently activate the dynorphin-kappa opioid system, which in turn can decrease dopaminergic activity in the mesocorticolimbic dopamine system. Blockade of the kappa opioid system can also block anxiety-like and reward deficits associated with withdrawal from drugs of abuse and block the development of compulsive-like responding during extended access to drugs of abuse, suggesting another powerful brain stress/anti-reward system that contributes to compulsive drug seeking. Thus, brain stress response systems are hypothesized to be activated by acute excessive drug intake, to be sensitized during repeated withdrawal, to persist into protracted abstinence, and to contribute to the development and persistence of addiction. The recruitment of anti-reward systems provides a powerful neurochemical basis for the negative emotional states that are responsible for the dark side of addiction. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据